NCT06960889Active, not recruiting
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Source: ClinicalTrials.gov · Last updated 14 Apr 2026
Brief summary (registry, in English)
This single-center, retrospective, 7-year observational study aims to investigate prognostic factors in esophageal cancer patients. Adults (≥18 years) with histologically confirmed esophageal cancer who received antitumor therapy between January 2017 and December 2024 were consecutively enrolled. Patient-level data (clinical characteristics, routine laboratory tests, tumor information, and treatment details) were retrospectively collected from electronic medical records to analyze key factors influencing treatment efficacy.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 29 Apr 2025
- Start date
- 15 Apr 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06960889
What you commit to
- Study type: Observational
- Planned participants: 500
- From 15 Apr 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent other malignancies
Other
- Patients deemed ineligible by investigators
Who the study is looking for
- Waiver of informed consent for deceased or lost-to-follow-up patients (January 2017-March 2024)
- Voluntary signed informed consent from surviving patients who could be contacted
- Treatment at Nanfang Hospital, Southern Medical University (January 2017-December 2024)
- Received antitumor therapy for esophageal cancer
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nanfang Hospital, Southern Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.